Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum
- 31 March 1997
- journal article
- Published by Elsevier in Molecular and Biochemical Parasitology
- Vol. 85 (1) , 25-40
- https://doi.org/10.1016/s0166-6851(96)02808-3
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The methotrexate story: A paradigm for development of cancer chemotherapeutic agentsAdvances in Enzyme Regulation, 1994
- Antimalarial drug resistance: the pace quickensJournal of Antimicrobial Chemotherapy, 1992
- Pyrimethamine resistant mutations in Plasmodium falciparumMolecular and Biochemical Parasitology, 1992
- Prevalence of the Dihydrofolate Reductase Asn-108 Mutation as the Basis for Pyrimethamine-Resistant Falciparum Malaria in the Brazilian AmazonThe American Journal of Tropical Medicine and Hygiene, 1991
- The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasitesPharmacology & Therapeutics, 1990
- Mutant dihydrofolate reductase-thymidylate synthase genes in pyrimethamine-resistant Plasmodium falciparum with polymorphic chromosome duplicationsMolecular and Biochemical Parasitology, 1990
- Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparumMolecular and Biochemical Parasitology, 1989
- Analogues of N-benzyloxydihydrotriazines:in vitroantimalarial activity againstPlasmodium falciparumPathogens and Global Health, 1986
- In vitro activities of and mechanisms of resistance to antifol antimalarial drugsAntimicrobial Agents and Chemotherapy, 1985
- Overproduction of a bifunctional thymidylate synthetase-dihydrofolate reductase and DNA amplification in methotrexate-resistant Leishmania tropica.Proceedings of the National Academy of Sciences, 1983